Sofokast Plus (Sofosbuvir & Daklatasvir)

Sofokast Plus (Sofosbuvir & Daklatasvir) is an effective innovative drug for the treatment of chronic hepatitis C in people over 18 years old, which is used in combination with other drugs in complex antiviral therapy. After numerous clinical trials, positive dynamics is observed in most patients with a weakened disease and is, moreover, quite stable. You can order Sofosbuvir for hepatitis C in our pharmacy at the best price.

Sofokast Plus (Sofosbuvir & Daklatasvir) is one of the latest modern German direct antiviral drugs that inhibit the NS5B polymerase of the hepatitis C virus. The therapeutic effect of the drug Sofosbuvir is achieved due to the active active substance of the same name, which suppresses the multiplication of the hepatitis C virus.

Sofosbuvir is an antisense nucleotide that inhibits the RNA-dependent RNA polymerase NS5B; this drug has earned a reputation as one of the strongest anti-replicative agents, including for interferon resistance.

Daclatasvir is a highly specific agent of direct action against the hepatitis C virus and does not have pronounced activity against other RNA and DNA viruses, including HIV . Daclatasvir is an inhibitor of non-structural protein 5A (NS5A), a multifunctional protein required for replication of the hepatitis C virus, and thus inhibits two stages of the viral life cycle – viral RNA replication and virion assembly.